Q-omics provides the consensus-scored ENPP7P10 profile across patient tissues and cancer cell-line models. ENPP7P10 expression is associated with patient survival in 23 of 34 cancer types, with the highest sampling consensus in UCS. Among the 18 cancer types available for tumor–normal comparison, ENPP7P10 is differentially expressed in 8, with the highest sampling consensus in THCA. Additionally, ENPP7P10 RNA expression shows 18,094 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight UCS, THCA, and THYM as cancer lineages where ENPP7P10 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for ENPP7P10 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes ENPP7P10 survival associations across molecular data types. ENPP7P10 RNA expression shows survival associations in the most cancer types (23). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible ENPP7P10 RNA expression–survival associations across cancer types. High ENPP7P10 expression shows unfavorable associations in COAD, LUSC and KIRP, but favorable associations in UCS, MESO and LAML. The UCS Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify UCS as the clearest survival context for ENPP7P10 RNA expression.
This table summarizes ENPP7P10 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 8. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for ENPP7P10. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. ENPP7P10 shows lower tumor expression in THCA, KICH, KIRC, UCEC and BRCA and higher tumor expression in HNSC. The THCA box plot shows higher ENPP7P10 RNA expression in normal versus tumor tissue (log2 FC = −0.390, t-test p < 0.001).
This table shows molecular features associated with ENPP7P10 in patient tissues and cancer cell lines. In patient samples, ENPP7P10 shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.
